# OnCo record nct02849496 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02849496/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02849496", "NCT02849496" ;
  schema:name "Olaparib with or without atezolizumab in BRCA-mutant breast cancer"@en ;
  schema:alternateName "Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer"@en ;
  schema:description "This study compares olaparib alone with olaparib plus atezolizumab in advanced BRCA-mutant breast cancer. It tests adding immune treatment to DNA-repair inhibition, rather than treatment after curative breast surgery."@en ;
  schema:url <https://onco.cc/trials/nct02849496/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02849496>, <https://clinicaltrials.ucsf.edu/trial/NCT02849496> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2017-03-30" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/olaparib/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .